Investigating the new wave of global women's health initiatives: beyond the glossy press releases, who controls the data and the destiny of female medical research?
The KU/Children's Mercy theranostics center is more than a building; it's a strategic play to dominate advanced nuclear medicine, leaving competitors flat-footed.
A massive $1.5M gift renames a women's center. But this isn't just philanthropy; it's a calculated move in the competitive landscape of regional healthcare branding.
Smart nanotech targeting tumors is here, but the real story is the coming war for control over personalized cancer therapy access.
New science reveals immune cells betray the body. This isn't just biology; it’s a massive regulatory failure in modern cancer treatment.
Rutgers scientists unveiled novel cancer cell tech. But the real story is the coming biotech consolidation and the war on drug patents.
The US celebrates 70% cancer survival, but this headline masks a brutal truth about access, cost, and the 'forgotten' diagnoses.
Russian scientists unveil a breakthrough cancer treatment technology. But the real story isn't the science; it's the geopolitical chessboard.
The 'guerrilla war on science' waged by political actors isn't just about abortion; it's a chilling blueprint for dismantling evidence-based medicine.
The recent Summit on Cancer Health Disparities (SCHD26) promised change, but the real fight against cancer health disparities is being ignored.
New research exposes the hidden survival trick of cancer relapse. This isn't just bad luck; it's engineered resilience we must confront.
PSG Hospitals' 2025 conference signals a shift in cancer care, but the real battleground is your plate, not just chemotherapy.